Neuraline
Back to BlogDocumentation & Clinical Templates

DSM-5-TR Criteria for Autism Spectrum Disorder (ASD) & Schizophrenia: Severity Levels & ICD-10 Codes

Neuraline TeamNovember 16, 202611 min read

Quick answer: ASD requires persistent deficits in social communication across all three domains plus restricted/repetitive behaviors, with onset in early development — severity levels 1–3 grade support needs. Schizophrenia requires ≥2 of 5 psychotic symptom domains (≥1 from delusions/hallucinations/disorganized speech) for ≥6 months with functional decline — coded F20.x.

Why These Two Diagnoses Belong in One Guide

ASD and schizophrenia sit in different DSM-5-TR chapters but share two things that make them the most-searched and most-consequential diagnoses to get right: both are defined by fixed, countable criteria (unlike the dimensional mood/anxiety disorders), and both carry lifetime stakes — an ASD determination drives school services, disability support, and developmental intervention, while a schizophrenia diagnosis drives antipsychotic treatment, monitoring, and disability documentation.

They also share a differential-diagnosis boundary: late-adolescent social withdrawal, odd speech, and restricted interests can present in either — and the distinction (premorbid developmental history vs. psychotic decline) is exactly where misdiagnosis happens. This guide serves psychiatrists, psychologists, developmental pediatricians, and primary care clinicians making referrals, with the documentation stakes explicit for each.

Part 1 — Autism Spectrum Disorder (ASD)

Criteria A & B — The Two Pillars

CriterionRequirementSub-criteria
A — Social communicationPersistent deficits in social communication and social interaction across contextsALL THREE required: (1) social-emotional reciprocity; (2) nonverbal communicative behaviors; (3) developing/maintaining/understanding relationships
B — Restricted/repetitiveRestricted, repetitive patterns of behavior, interests, or activities≥2 of 4: (1) stereotyped/repetitive motor movements or speech; (2) insistence on sameness/inflexible routines; (3) highly restricted fixated interests of abnormal intensity; (4) hyper- or hyporeactivity to sensory input
C — OnsetSymptoms present in the early developmental periodMay not fully manifest until social demands exceed capacities
D — ImpairmentClinically significant impairment in social, occupational, or other important areasCurrent functioning, not potential
E — ExclusionsNot better explained by intellectual disability or global developmental delaySocial communication deficits must exceed what general developmental level predicts

Severity Levels — What Levels 1/2/3 Actually Mean

LevelSupport neededSocial communicationRestricted/repetitive behaviors
Level 1Requiring supportNoticeable deficits without supports; may appear awkwardInflexibility causes significant interference in one or more contexts
Level 2Requiring substantial supportMarked deficits apparent even with supports; limited initiation of social interactionInflexibility or restricted behaviors apparent to casual observers; interfere with functioning in multiple contexts
Level 3Requiring very substantial supportSevere deficits in verbal/nonverbal communication; very limited initiation; minimal response to social approachesInflexibility/behaviors markedly interfere with functioning in all spheres; great distress when changed

ASD Specifiers

SpecifierOptions
Intellectual impairmentWith or without accompanying intellectual impairment
Language impairmentWith or without accompanying language impairment
Associated conditionsAssociated with another neurodevelopmental, mental, or behavioral disorder (specify)
CatatoniaWith catatonia

Diagnostic Instruments (Not Screeners)

InstrumentPurposeWho administers
ADOS-2Gold-standard observational assessment of social communication + restricted behaviorsTrained clinician
ADI-RParent/caregiver interview on developmental historyTrained clinician
M-CHAT-R/FToddler screening (16–30 months)Parent completes; positive → referral

ASD Differential — What Else Looks Like Autism

DifferentialDistinguishing features
Intellectual disabilityGlobal cognitive deficits; social communication deficits do not exceed what the developmental level predicts — if they do, ASD is comorbid and both are coded
Social (pragmatic) communication disorderSocial communication deficits without restricted/repetitive behaviors (criterion B) — if criterion B is present, it's ASD
SchizophreniaPsychotic decline with delusions/hallucinations and loss of previously acquired skills; ASD shows lifelong, stable-at-core patterns with early onset
ADHDDistractibility and social difficulties from inattention, not from reciprocity deficits; frequently comorbid — both can be coded
Reactive attachment / traumaSocial withdrawal follows neglect or disruption; improves with stable caregiving; no restricted/repetitive criterion-B behaviors

Severity levels are functional, not fixed traits. Level 1/2/3 describes current support needs — a child can move levels across development as demands change (a level-1 presentation in elementary school can become level-2 in middle school's unstructured social environment). Re-assess and update the specifier at each major transition; the level is part of the documented diagnosis, not a permanent label.

Sample documentation:

Patient meets DSM-5-TR criteria for Autism Spectrum Disorder, Level 2 requiring substantial support, without accompanying intellectual impairment (F84.0): deficits in all three social communication domains (limited reciprocity, flat prosody and reduced eye contact, difficulty maintaining peer relationships) plus 3 of 4 criterion-B behaviors (hand-flapping, insistence on sameness with distress at routine changes, circumscribed interest in train schedules, auditory hyperreactivity). Onset in early development per caregiver report and school records. ADOS-2 administered — scores consistent with ASD. Not better explained by intellectual disability (FSIQ 95).

Part 2 — Schizophrenia

The 5 Psychotic Symptom Domains

DomainExamplesRequired?
DelusionsFixed false beliefs despite contradictory evidenceAt least one of these three is required
HallucinationsPerception without external stimulus (auditory most common)
Disorganized speechFrequent derailment/incoherence, tangentiality, word salad
Grossly disorganized or catatonic behaviorDaily-life dysfunction, unpredictable agitation, catatoniaOptional (only 2 domains needed if these are present)
Negative symptomsDiminished emotional expression, avolition, alogia, anhedonia, asocialityOptional

Duration and Course Criteria

CriterionRequirement
Symptom count≥2 of 5 domains for a significant portion of time during a 1-month period (or less if successfully treated)
Mandatory domainAt least one of: delusions, hallucinations, or disorganized speech
Total durationContinuous signs of the disturbance persist for ≥6 months; the 1-month active phase must be included within it
Prodromal/residualThe 6-month period includes prodromal or residual symptoms (may be negative symptoms or attenuated psychotic symptoms)
Functional declineLevel of functioning in work/school/relationships is markedly below premorbid level (or failure to achieve expected level in youth)
ExclusionsNot attributable to substances or another medical condition; not better explained by schizoaffective, depressive, or bipolar disorder with psychotic features

Schizophrenia Spectrum — Differential Table

DisorderDSM-5-TR codeDurationDistinguishing feature
SchizophreniaF20.x≥6 months (≥1 month active)Functional decline; negative symptoms
SchizophreniformF20.811–6 monthsSame symptoms, shorter duration, recovery expected
Brief psychoticF231 day–1 monthFull return to premorbid functioning
SchizoaffectiveF25.x≥6 monthsMood episode + ≥2 weeks psychosis without mood episode
DelusionalF22≥1 monthDelusions only; functioning preserved outside delusion
Substance/medication-inducedF1x.5/F05VariableTemporally related to substance or GMC
Psychotic disorder due to GMCF06.2VariableAttributable to another medical condition

ICD-10-CM F20.x Code Map

CodeDiagnosis
F20.0Paranoid schizophrenia
F20.1Disorganized schizophrenia
F20.2Catatonic schizophrenia
F20.3Undifferentiated schizophrenia
F20.5Residual schizophrenia
F20.81Schizophreniform disorder
F20.89Other schizophrenia spectrum disorders
F20.9Schizophrenia, unspecified

The Rule-Out Order — Before Coding Any Psychotic Disorder

Work the differential in this order, because each step excludes the next:

  1. Substances — stimulant intoxication, cannabis-induced psychosis, corticosteroids (urine drug screen + medication review)
  2. Medical conditions — thyroid disease, autoimmune encephalitis, temporal lobe epilepsy, delirium (TSH, CBC, metabolic panel, neuro exam)
  3. Mood disorders with psychotic features — psychosis only during mood episodes = mood disorder with psychotic features, not schizophrenia
  4. Developmental context — ASD with atypical presentation is not psychosis; obsessions with absent insight are not delusions

First-episode psychosis pathway: for a first presentation, document the timeline carefully — prodromal period (social withdrawal, avolition, odd beliefs), active-phase onset, and functional decline. Duration determines the code: 1 day–1 month → brief psychotic disorder (F23); 1–6 months → schizophreniform (F20.81); ≥6 months → schizophrenia (F20.x). Schizophreniform is the provisional diagnosis while the course clarifies.

Clinical high risk (CHR/UHR) screening: the CAARMS (Comprehensive Assessment of At-Risk Mental States) identifies attenuated psychotic symptoms in help-seeking adolescents and young adults before full criteria are met. CHR states are documented as "other specified schizophrenia spectrum disorder" (F28/F29) — not schizophrenia — and justify monitoring rather than antipsychotic initiation in most guidelines.

Sample documentation:

Patient meets DSM-5-TR criteria for Schizophrenia (F20.9): auditory hallucinations (commenting voices) and persecutory delusions present for 5 months, with 8 months of prodromal social withdrawal and avolition. Functioning declined from full-time employment. Urine drug screen negative; TSH, CBC, metabolic panel unremarkable; no mood episodes meeting criteria. Olanzapine initiated; metabolic monitoring scheduled.

Cross-Diagnosis Comparison

FeatureASDSchizophrenia
ChapterNeurodevelopmentalSchizophrenia Spectrum & Other Psychotic
OnsetEarly developmental periodTypically late adolescence/early adulthood
Core deficitSocial communication + restricted behaviorsPsychotic symptoms (delusions/hallucinations/disorganization)
InsightPreserved (may be odd but not psychotic)Impaired during active phase
CourseLifelong neurodevelopmentalEpisodic with possible residual phase
ICD-10-CMF84.0F20.x
Severity measureLevels 1–3 (support needs)Specifiers: severity, course, catatonia

Screening and Assessment in the EHR

Neither ASD nor schizophrenia has a PHQ-9-style brief screen that establishes the diagnosis — the workup runs on structured instruments and longitudinal observation:

DiagnosisInstrumentsWorkflow
ASDADOS-2 + ADI-R (diagnostic), M-CHAT-R/F (toddler screen)Positive M-CHAT → referral for ADOS-2/ADI-R; caregiver developmental history is criterion evidence
Schizophrenia (CHR)CAARMSAttenuated symptoms → F28/F29 monitoring, not antipsychotics
Schizophrenia (established)PANSS / BPRS (severity tracking)Serial scores document treatment response
Comorbidity screensPHQ-9, GAD-7, MMSEDepression and anxiety co-occur with both; cognition in psychosis

In Neuraline, the AI Screening module carries the comorbidity layer — PHQ-9, GAD-7, Y-BOCS, BDI, HAM-D, and MMSE pre-seeded with auto-scoring and severity bands — while encounter templates hold the structured criteria checklists for ASD (criteria A/B with all sub-items) and schizophrenia (5 domains + duration). 3-click AI Charting drafts the note with instrument scores, criteria checklists, and the coded diagnosis embedded — draft, review, sign. For ASD specifically, caregiver-reported developmental history attaches to the encounter as documentation supporting the early-onset criterion.

Frequently Asked Questions

What are ASD severity levels 1, 2, and 3?

They grade current support needs, not ability: Level 1 = requiring support (noticeable deficits without supports); Level 2 = requiring substantial support (marked deficits apparent even with supports); Level 3 = requiring very substantial support (severe deficits, minimal initiation or response to social approaches). Levels are reassessed as development and environment change.

Can someone have both ASD and schizophrenia?

Yes — DSM-5-TR explicitly allows comorbid ASD and schizophrenia when both criteria sets are independently met. Historically the diagnoses were considered mutually exclusive (DSM-III/IV "pervasive developmental disorder" exclusion); DSM-5 removed that exclusion. Document both with separate codes (F84.0 + F20.x) when both are established.

How long must symptoms last for a schizophrenia diagnosis?

≥6 months of continuous disturbance, which must include at least 1 month of active-phase symptoms (≥2 of the 5 domains, at least one being delusions, hallucinations, or disorganized speech). Prodromal and residual periods count toward the 6 months. Under 6 months → schizophreniform; under 1 month → brief psychotic disorder.

What code do I use for autism with intellectual impairment?

The base code is still F84.0 — intellectual impairment is a specifier ("with accompanying intellectual impairment"), documented in the note. If intellectual disability is also independently diagnosed, code both: F84.0 + F70–F79 as applicable. The severity level (1/2/3) is likewise documented, not coded.


This guide summarizes DSM-5-TR criteria for clinical reference. Diagnosis requires a qualified clinician's evaluation — screeners and checklists support but never replace the diagnostic interview.

Neuraline's AI Screening module automates instrument scoring and severity tracking across your practice. Explore screening or book a demo.

About Neuraline

Neuraline (neura-line.com) is an AI-powered Electronic Health Record (EHR), practice management, and medical billing platform for independent healthcare practices.

Follow Neuraline on LinkedIn

See Neuraline in Action

Ready to transform your practice with AI-powered EHR? Schedule a personalized demo today.

Request Your Demo